Abstract
The role of hypoxic cell radiosensitisers in the management of cancer in patients has been the subject of several meetings (1,2) including the present one. This report concerns itself with some clinical studies carried out by the author and his colleagues at Cambridge, England, principally with misonidazole (Ro 07-0582 Roche Laboratories, N.S.C. 261037) and more recently with its O-demethylated metabolite, desmethylmisonidazole (Ro 05-9963, Roche Laboratories, N.S.C. 261036).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hypoxic Cell Sensitisers in Radiobiology and Radiotherapy. 8th L. H. Gray Conference, Cambridge 5th–9th Sept. 1977. Br. J. Cancer 38:Suppl. II (1978).
Combined Modality Cancer Treatment. Radiation Sensitiser and Protectors Meeting. Key Biscayne, Florida. Oct. 3rd–6th, 1979. Cancer Clinical Trials 3: in press (1980).
C. R. Wiltshire, P. Workman, J. V. Watson and N. M. Bleehen, Clinical Studies with Misonidazole. Br.J.Cancer 37:Suppl.III, Br.J.Cancer 37:Suppl.III, 286 (1978).
P. Workman, C. R. Wiltshire, P. N. Plowman and N. M. Bleehen, Monitoring Salivary Misonidazole in Man: A possible alternative to plasma monitoring. Br.J.Cancer 38: 709 (1978).
P. Workman, N. M. Bleehen and C. R. Wiltshire, Phenytoin shortens the half-life of the hypoxic cell radiosensitiser misonidazole in man: Implications for possible reduced toxicity. Br.J.Cancer 41: 307 (1980).
N. M. Bleehen, The Cambridge Glioma Trial of Misonidazole and Radiation Therapy with Associated Pharmacokinetic Studies. Cancer Clinical Trials 3:in press (1980).
G. E. Adams, I. R. Flockhart, C. E. Smithen, I. J. Stratford, P. Wardman and M. E. Watts, Electron affinie Sensitisation, VII: A correlation between structures, one-electron reduction potential and efficiencies of nitroimidazoles as hypoxic cell radiosensitisers. Radiat. Res. 67:9 (1976).
I. R. Flockhart, P. W. Sheldon, I. J. Stratford and M. J. Watts, A Metabolite of the 2-nitroimidazole Misonidazole with Radio- sensitising properties. Int. J. Radiat Biol. 34: 91 (1978).
J. M. Brown, N. Y. Yu and P. Workman, Pharmacokinetic consider-ations in testing Hypoxic Cell Radiosensitisers in Mouse Tumours. Br. J. Cancer 39: 310 (1979).
P. Workman, C. J. Little, T. R. Marten, A. D. Dale, R. J. Ruane, I. R. Flockhart and N. M. Bleehen, Estimation of the Hypoxic Cell Sensitiser Misonidazole and its 0-demethylated metabolite in biological materials by reversed-phase high performance liquid chromatography. J, Chromatoff. 145: 507 (1978).
P. Workman, Effects of pretreatment with Phenobarbitone and Phenytoin on the Pharmacokinetics and Toxicity of Misonidazole in Mice. Br.J.Cancer 40: 335 (1979).
S. Dische, M. I, Saunders, P. Anderson, R. C. Urtasun, K. H, Karcher, H. D. Kogelnik, N. H. Bleehen, T. L. Phillips, T. H. Wasserman, The Neurotoxicity of Misonidazole: pooling data from five centres. Br.J.Radiol. 51: 1023 (1978).
T. H. Wasserman, T. L. Phillips, G. Van Raalte, R. Urtasun, J. Partington, D. Koziol, J. G. Schwade, D. Gangji and J. M. Strong, The Neurotoxicity of Misonidazole: potential modifying role of phenytoin sodium and dexamethasone. Br.J.Radiol. 53: 172 (1980).
P. Workman, The Neurotoxicity of Misonidazole: potential modifying role of dexamethasone. Br.J.Radiol. 53: 736 (1980).
D. Ash, M. R. Smith and R. Bugden, The distribution of Misonidazole in Human Tumours and Normal Tissues. Br.J.Cancer 39: 503–509, 1979.
S. Dische, M. I. Saunders, M. E. Lee, G. E. Adams and I. R. Flockhart, Clinical Testing of the Radiosensitiser Ro 07-0582. Experience with multiple doses. Br.J.Cancer 35: 567 (1977).
R. C. Urtasun, J. D. R. Miller, V. Frunchak, D. Koziol, P. R. Band, J. D. Chapman and M. L. Feldstein, Radiotherapy Pilot Trials with Sensitisers of Hypoxic Cells: Metronidazole in supratentorial glioblastomas. Br.J.Radiol. 50: 602 (1977).
S. Hornsey and A. White, Isoeffect Curve for Radiation Myelopathy. Br.J.Radiol. 53: 168 (1980).
A. J. Van der Kogel, Late Effects of Radiation on the Spinal Cord. Dose effect relationships and pathogenesis. T.N.0., Rijswijk, Holland (1979).
J. Denekamp, N. J. McNally and J.F. Fowler, Misonidazole in Fractionated Radiotherapy: Little and often? Br.J.Radiol.: in press.
J. F. Fowler, G. E. Adams and J. Denekamp, Radiosensitisers of Hypoxic Cells in Solid Tumours. Cancer Treat. Rev. 3: 227 (1976).
J. M. Yuhas, Misonidazole Enhancement of Acute and Late Radiation Injury to Rat Spinal Cord. Br.J.Cancer 40: 161 (1979).
R. A. S. White and P. Workman, Pharmacokinetic and Tumour- penetration Properties of the Hypoxic Cell Radiosensitiser Desmethylmisonidazole (Ro 05-9963) in Dogs. Br.J.Cancer 41: 268 (1980).
M. I. S. Saunders, S. Dische, P. Anderson and I. R. Flockhart, The Neurotoxicity of Misonidazole and its relationship to dose, half-life and concentration in serum. Br.J.Cancer 37 (Suppl.III): 268 (1978).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Press, New York
About this chapter
Cite this chapter
Bleehen, N.M. (1982). Pharmacokinetic and Therapeutic Studies with Misonidazole and Desmethylmisonidazole in Man. In: Breccia, A., Cavalleri, B., Adams, G.E. (eds) Nitroimidazoles. NATO Advanced Study Institutes Series, vol 42. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4151-2_15
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4151-2_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4153-6
Online ISBN: 978-1-4684-4151-2
eBook Packages: Springer Book Archive